BioRestorative Therapies, Inc. (BRTX)

BioRestorative Therapies Revenue

BioRestorative Therapies had revenue of $23.17K in the quarter ending March 31, 2026, a decrease of -7.32%. This brings the company's revenue in the last twelve months to $357.87K, down -8.47% year-over-year. In the year 2025, BioRestorative Therapies had annual revenue of $359.70K, down -10.30%.

• Revenue (ttm): $357.87K
• Revenue Growth: -8.47%
• P/S Ratio: 26.11
• Revenue / Employee: $25,562
• Employees: 14
• Market Cap: 9.22M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	359.70K	-41.30K	-10.30%
Dec 31, 2024	401.00K	255.20K	175.03%
Dec 31, 2023	145.80K	26.00K	21.70%
Dec 31, 2022	119.80K	73.80K	160.43%
Dec 31, 2021	46.00K	-31.00K	-40.26%
Dec 31, 2020	77.00K	-53.00K	-40.77%
Dec 31, 2019	130.00K	19.00K	17.12%
Dec 31, 2018	111.00K	30.00K	37.04%
Dec 31, 2017	81.00K	44.65K	122.80%
Dec 31, 2016	36.36K	-592.56K	-94.22%
Dec 31, 2015	628.92K	212.92K	51.18%
Dec 31, 2014	416.00K	414.32K	24,661.67%
Dec 31, 2013	1.68K	-13.91K	-89.22%
Dec 31, 2012	15.59K	-	-
Dec 31, 2011	-	-	-
Dec 31, 2010	-	-	-

Data Source: Fiscal.ai Last updated: May 14, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 5, 2026

Data Sources Report a data error